SALT OF OMECAMTIV MECARBIL AND PROCESS FOR PREPARING SALT

To provide a novel salt and polymorph form of omecamtiv mecarbil useful as a therapeutic agent of cardiac failure.SOLUTION: Omecamtiv mecarbil dihydrochloride salt having the following structure. Preferably, the salt shows an x-ray powder diffraction pattern comprising peaks at about 6.6, 14.9, 20.1...

Full description

Saved in:
Bibliographic Details
Main Authors CHARLES BERNARD, KARTHIK NAGAPUDI, JACQUELINE WOO, NEIL FRED LANGILLE, CUI SHENG, MUCI ALEX, SHAWN WALKER, ALAN MARTIN ALLGEIER, STEVEN MENNEN, KARL BENNETT HANSEN, BRADLEY PAUL MORGAN, HENRY MORRISON
Format Patent
LanguageEnglish
Japanese
Published 20.08.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To provide a novel salt and polymorph form of omecamtiv mecarbil useful as a therapeutic agent of cardiac failure.SOLUTION: Omecamtiv mecarbil dihydrochloride salt having the following structure. Preferably, the salt shows an x-ray powder diffraction pattern comprising peaks at about 6.6, 14.9, 20.1, 21.4, and 26.8±0.2°2θ using Cu Kα radiation, and is of a crystal form having an endothermic transition at about 230°C to about 240°C as measured by differential scanning calorimetry.SELECTED DRAWING: None 【課題】心不全の治療薬として有用なオメカムチブメカルビルの新規な塩及び多形結晶形状の提供。【解決手段】下記構造を有するオメカムチブメカルビルのジヒドロクロリド塩。前記塩は、CuKα照射を使用して、約6.6、14.9、20.1、21.4及び26.8±0.2°2θでのピークを含むX線粉末回折パターンを示し、示差走査熱量測定によって測定される場合、約230℃〜約240℃での吸熱転移を有する結晶形態であることが好ましい。【選択図】なし
Bibliography:Application Number: JP20200069487